Literature DB >> 9585779

Prognostic factors for adenocarcinoma of the gallbladder: an analysis of 162 cases.

J H North1, M S Pack, C Hong, D E Rivera.   

Abstract

Carcinoma of the gallbladder is a rare neoplasm and is associated with a dismal prognosis. To analyze the natural history of this disease and prognostic factors, a large tumor registry database was accessed. During the period 1972 to 1995, 214 patients were entered. Adequate follow-up was available on 162 patients, and this group forms the basis of this review. There were 54 males and 108 females with a median age of 62 years. Median follow-up was 7 months. Right upper quadrant abdominal pain was the most frequent presenting symptom. Fifteen patients had an incidental finding of carcinoma after cholecystectomy. Overall, 5-year survival was 25 per cent, with a median survival time of 9.7 months. Survival was improved for patients with local disease compared with those with regional or metastatic disease. One hundred nine patients underwent surgical therapy. Complete resection was possible in 36 patients, whereas 44 patients had residual disease. Median survival time for patients with no residual disease was 67.2 months, whereas those for patients with microscopic residual tumor and gross residual tumor were 8.9 and 3.8 months, respectively (P < 0.000001). Gallbladder cancer is often diagnosed at an advanced stage and is associated with a poor prognosis. In patients with localized disease, surgical treatment provides the opportunity for long-term survival only when a complete resection can be performed. Prognosis for patients with microscopic residual and gross residual disease is similar.

Entities:  

Mesh:

Year:  1998        PMID: 9585779

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  9 in total

1.  Prognostic factors in gallbladder and biliary tract cancer.

Authors:  Xóchitl Gómez-Roel; Oscar Arrieta; Eucario León-Rodríguez
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Does radical resection improve the survival in patients with carcinoma of the gallbladder who are 75 years old and older?

Authors:  Hirohiko Onoyama; Tetsuo Ajiki; Moriatsu Takada; Tomoaki Urakawa; Yoichi Saitoh
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

3.  Analysis of trefoil factor family protein 1 (TFF1, pS2) expression in chronic cholecystitis and gallbladder carcinoma.

Authors:  Peter Kornprat; Peter Rehak; Martina Lemmerer; Margit Gogg-Kamerer; Cord Langner
Journal:  Virchows Arch       Date:  2005-04-09       Impact factor: 4.064

4.  Carcinomatous meningitis as the presenting manifestation of gallbladder carcinoma: case report and review of the literature.

Authors:  Yue Shen; Deborah T Blumenthal; Kathleen Digre; Melissa H Cessna; Evelyn V Gopez
Journal:  J Neurooncol       Date:  2004-10       Impact factor: 4.130

5.  Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.

Authors:  P Kornprat; P Rehak; J Rüschoff; C Langner
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

Review 6.  Surgical management of gallbladder carcinoma: a review.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

Review 7.  [Gallbladder and bile duct carcinoma. Biology and pathology].

Authors:  A Tannapfel; C Wittekind
Journal:  Internist (Berl)       Date:  2004-01       Impact factor: 0.743

8.  A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?

Authors:  Danielle M Hari; J Harrison Howard; Anna M Leung; Connie G Chui; Myung-Shin Sim; Anton J Bilchik
Journal:  HPB (Oxford)       Date:  2012-09-26       Impact factor: 3.647

9.  Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience.

Authors:  Hiromichi Ito; Evan Matros; David C Brooks; Robert T Osteen; Michael J Zinner; Richard S Swanson; Stanley W Ashley; Edward E Whang
Journal:  J Gastrointest Surg       Date:  2004-02       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.